1383385-09-8

Basic information

• Product Name: C₂₅H₃₆N₂O₂S
• Synonyms: C₂₅H₃₆N₂O₂S
• CAS NO: 1383385-09-8
• Molecular Weight: 428.639
• Mol File: 1383385-09-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₂₅H₃₆N₂O₂S(CAS DataBase Reference)
• NIST Chemistry Reference: C₂₅H₃₆N₂O₂S(1383385-09-8)
• EPA Substance Registry System: C₂₅H₃₆N₂O₂S(1383385-09-8)

Safety Data

• Hazardous Substances Data: 1383385-09-8(Hazardous Substances Data)

Upstream product

• 1383385-02-1 C₂₀H₂₉NO₂S 
• 1383385-01-0 C₂₀H₂₆NO₂S⁽¹⁺⁾*I^(1-) 
• 1383384-93-7 C₁₈H₂₁NO₂S 
• 1383384-92-6 C₁₈H₁₉NO₂S 
• 1383384-91-5 C₁₁H₈BrNO₂S 
• 62353-77-9 3-iodothiophene-2-carboxylic acid methyl ester 
• 108-94-1 cyclohexanone 
• 1383385-03-2 C₂₀H₂₈INO₂S 
• 2978-58-7 1,1-dimethylprop-3-ynylamine 
• 865869-26-7 4,4,5,5-tetramethyl-2-(4-methylcyclohex-1-en-1-yl)-1,3,2-dioxaborolane 
• 119472-66-1 4-methylcyclohex-1-en-1-yl trifluoromethanesulfonate 
• 22288-78-4 Methyl 3-aminothiophene-2-carboxylate 

Downstream Products

• 1383385-10-1 C₂₇H₄₀N₂O₂S 
• 1383383-30-9 5-(3-amino-3-methyl-but-1-ynyl)-3-(1-ethyl-5-(4-methyl-cyclohexyl)-1,2,3,6-tetrahydro-pyridin-4-yl)-thiophene-2-carboxylic acid 

Relevant articles and documents

INHIBITORS OF HEPATITIS C VIRUS POLYMERASE

The present invention provides, among other things, compounds represented by the general Formula (I) and pharmaceutically acceptable salts thereof, wherein X, Y, R1A, R1B, R2, and R3 are as defined in classes and subclasses herein and compositions (e.g., pharmaceutical compositions) comprising such compounds, which compounds are useful as inhibitors of hepatitis C virus polymerase, and thus are useful, for example, as medicaments for the treatment of HCV infection.